Is Serum Thyroglobulin a Useful Marker for Thyroid Cancer in Patients Who Have Not Had Ablation of Residual Thyroid Tissue?
Author:
Publisher
Mary Ann Liebert Inc
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.liebertpub.com/doi/pdf/10.1089/thy.1997.7.343
Reference19 articles.
1. Classification and prognosis of thyroid carcinoma
2. Papillary and follicular thyroid cancer
3. Papillary Thyroid Carcinoma
4. Papillary thyroid carcinoma: A 10 year foliow-up report of the impact of therapy in 576 patients
5. Report of the consensus development conference on the management of differentiated thyroid cancer in the Netherlands
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis;The Journal of Clinical Endocrinology & Metabolism;2024-08-16
2. Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis;The Journal of Clinical Endocrinology & Metabolism;2022-11-04
3. Serum Thyroglobulin Measurement Following Surgery Without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review;Thyroid;2022-06-01
4. Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis;Clinical Chemistry and Laboratory Medicine (CCLM);2022-04-28
5. Current surgical treatment of intermediate risk differentiated thyroid cancer: a systematic review;Expert Review of Anticancer Therapy;2020-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3